In response to a recent published study carried out in the USA concerning prostate cancer diagnosis and treatment after the introduction of PSA screening [3], we have already discussed the fact that the introduction two decades ago of PSA-based screening techniques cannot explain the persisting growing incidence of prostate cancer in many developed countries [4]. The gene discussed is KLK3; the disease is Familial prostate cancer.